サイクリンA1
207 (2): 408–418. (1999). doi:10.1006/dbio.1998.9156. PMID 10068472.
“Cyclin A1 expression in leukemia and normal hematopoietic cells”. Blood 93 (6): 2067–2074. (1999). PMID 10068680.
“Cloning of the cyclin A1 genomic structure and characterization of the promoter region. GC boxes are essential for cell cycle-regulated transcription of the cyclin A1 gene”. J. Biol. Chem. 274 (16): 11220–11228. (1999). doi:10.1074/jbc.274.16.11220. PMID 10196209.
“BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site”. Mol. Cell. Biol. 19 (7): 4843–4854. (1999). doi:10.1128/MCB.19.7.4843. PMC 84283. PMID 10373534. https://www.ncbi.
“G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently”. J. Biol. Chem. 268 (11): 8298–8308. (1993). PMID 8463339.
“A distinct cyclin A is expressed in germ cells in the mouse”. Development 122 (1): 53–64. (1996). PMID 8565853.
“BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases”. Oncogene 15 (2): 143–157. (1997). doi:10.1038/sj.onc.1201252. PMID 9244350.
“Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene 200 (1–2): 149–156.
“Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins”. Oncogene 11 (8): 1581–1588. (1995). PMID 7478582.
“Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation”. Mol. Cell. Biol. 14 (12): 8420–8431. (1994). doi:10.1128/MCB.14.12.8420. PMC 359381. PMID 7969176. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC359381/.
“Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides”. Gene 138 (1–2): 171–174. (1994). doi:10.1016/0378-1119(94)90802-8. PMID 8125298.